Records collected on Tuesday, August 4, 2026
66 records, grouped by source. Every entry links to the official source.
U.S. Department of Justice 15
- Two Companies Agree to Pay Over $2.3 Million to Resolve False Claims Act Allegations Relating to Paycheck Protection Program Loans
- BATON ROUGE MAN SENTENCED TO 48 MONTHS IN FEDERAL PRISON FOR CONSPIRACY TO COMMIT BANK FRAUD AND THEFT OF MAIL
- Coral Gables Woman Pleads Guilty to Impersonating Federal Immigration Official to Dismiss Removal Proceedings
- California Man Pleads Guilty to Role in Phantom Hacker Scheme Targeting Elderly Victims
- Fayetteville Resident Charged in Nearly $1 Million Pandemic Relief Scam
- Romanian Alien Trio Collectively Sentenced to More Than 11 Years in Federal Prison for ATM "Skimming" Scheme
- Silver Spring Woman Sentenced to More Than Three Years in Federal Prison for Role in COVID Fraud Scheme
- Former Postal Worker Admits to Repeatedly Burglarizing Post Offices to Steal Mail
- U.S. Attorney Phillip W. Williams Jr. Joins the Department of Justice to Announce Unprecedented Fraud Enforcement Actions Across the Southeast
- Bronx Man Sentenced to 58 Months in Prison for Multi-State Identify Theft and Bank Fraud Ring
- United States Attorney’s Office Files Civil Forfeiture Action to Recover Approximately $1.4 Million in Proceeds of Insider Trading Scheme
- Air Force Active Duty Member Settles False Claims Act Allegations for Fraudulent Government Loan
- Crestview Woman Federally Indicted for Fraud Offenses Totaling Over Four Million Dollars
- Medicare Advantage Provider Complete Health to Pay $14,100,000 to Settle False Claims Act Suit
- United States Attorney’s Office Joining Law Enforcement, Community Leaders and Residents for National Night Out Events
U.S. Securities and Exchange Commission 3
Company filings on SEC EDGAR 2
U.S. Food and Drug Administration 18
- FDA Class II: Rohto-Mentholatum (Vietnam) Co., Ltd. — Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Steril
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per car
- FDA Class II: Rohto-Mentholatum (Vietnam) Co., Ltd. — Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%), Sterile
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per c
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per c
- FDA Class II: Fresenius Kabi USA, LLC — Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-fiv
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per c
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per c
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per c
- FDA Class II: Rohto-Mentholatum (Vietnam) Co., Ltd. — Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL O
- FDA Class II: Fresenius Kabi USA, LLC — Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vial
- FDA Class II: Rohto-Mentholatum (Vietnam) Co., Ltd. — Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10 mL)
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per c
- FDA Class II: Fresenius Kabi USA, LLC — Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per via
- FDA Class II: Rohto-Mentholatum (Vietnam) Co., Ltd. — Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), Sterile
- FDA Class II: Ascend Laboratories, LLC — Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactur
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per car
- FDA Class II: Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per
International Trade Administration, U.S. Department of Commerce 3
- Van-Type Trailers and Subassemblies Thereof From Mexico: Preliminary Affirmative Determination of Sales at Less Than Fair Value, Postponement of Final Determination, and Extension of Provisional Measures
- Van-Type Trailers and Subassemblies Thereof From Canada: Preliminary Affirmative Determination of Sales at Less Than Fair Value, Postponement of Final Determination, and Extension of Provisional Measures
- Chassis and Subassemblies Thereof From the People's Republic of China: Final Results of the Expedited First Sunset Review of the Antidumping Duty Order
U.S. International Trade Commission 10
- Fresh Mushrooms From Canada; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
- Linear Hydraulic Cylinders From Canada, China, India, Mexico, and South Korea; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations
- Certain Radio Control Transmitters and Receivers and Products Containing Same; Notice of Commission Determination To Institute a Modification Proceeding; Modify a Limited Exclusion Order; and Terminate the...
- Certain Portable Battery Jump Starters and Components Thereof; Notice of Commission Determination to Institute a Rescission Proceeding; Rescind a Limited Exclusion Order; and Terminate the Rescission Proceeding
- Certain Computer Cables, Chargers, Adapters, Peripheral Devices and Packaging Containing the Same; Notice of Commission Determination To Institute a Rescission Proceeding; Rescind a Limited Exclusion Order; and...
- Certain Arrowheads With Deploying Blades and Components Thereof; Notice of Commission Determination To Institute a Modification Proceeding; Modify a General Exclusion Order; and Terminate the Modification Proceeding
- Certain Portable Power Stations and Packaging Therefor; Notice of Commission Determination To Institute a Modification Proceeding; Modify a Limited Exclusion Order; and Terminate the Modification Proceeding
- Certain Mobile Cellular Communications Devices; Notice of a Commission Determination Not To Review an Initial Determination Terminating All Remaining Respondents From the Investigation; Termination of the Investigation
- Corrosion Inhibitors From China; Determinations
- Difluoromethane (R-32) From China; Determination
Other federal agencies (via the Federal Register) 2
- Accessible Lavatories on Single-Aisle Aircraft and Ensuring Safe Accommodations for Air Travelers With Disabilities Using Wheelchairs
- Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020
Federal and state courts (via CourtListener) 13
- Chris M Bolte v. Dubois County Assessor
- Securities and Exchange Commission v. Wisdom Capital Management Group Ltd
- Riviera Northgate Apartments Llc, Res. V. Ruby Caine And All Other Occupants, Apps.
- Cluck v. GEO Secure Services
- HKA Global LLC v. Christopher Beirise
- Gilead Tenofovir Cases
- L.A. County Employees Retirement Association v. County of L.A.
- Gregory J. McCray v. FDH Holdings, LLC, FDH Infrastructure Group, Julian Mashand John Robinson
- Leon Rengel v. United States
- GreenLatinos v. Suncor Energy (U.S.A.)
- Dan Pennington v. BHP Billiton Petrol (Fayetteville)
- R.M. v. State
- In re Miguel J.